The Miami longevity startup says it hopes to reach human trials during the nine-month program, after extensive preclinical development.

Link as first comment.

#longevity #humantrials #preclinical #Miami #startup

#Drug doubles life expectancy of pancreatic cancer patients 💊

The #FDA approved #daraxonrasib, from Revolution Medicines, after patients in a #Phase3 clinical trial lived twice as long as those on #chemotherapy. The drug was studied in #mice and #monkeys before #HumanTrials.

🔗 shorturl.at/BHYZd